MXRA5 has also been described to be a promising marker of early tissue injury and fibrosis (19), and its application has been extensively investigated in experimental studies of myocardial damage, kidney cancer, and chronic kidney disease (19, 30). The gene discussed is MXRA5; the disease is chronic kidney disease.